These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 38991687)
1. Are adverse events higher among patients with acute optic neuritis prescribed glucocorticoids? A retrospective, longitudinal cohort study. De Lott LB; Brennan B; Wallace B; Kerber K; Burke JF; Roslin C; Terman S; Andrews C; Waljee AK; Banerjee M BMJ Open; 2024 Jul; 14(7):e076801. PubMed ID: 38991687 [TBL] [Abstract][Full Text] [Related]
2. Predictors of Glucocorticoid Use for Acute Optic Neuritis in the United States, 2005-2019. De Lott LB; Lin CC; Burke JF; Wallace B; Saukkonen D; Waljee AK; Kerber KA Ophthalmic Epidemiol; 2023 Feb; 30(1):88-94. PubMed ID: 35168450 [TBL] [Abstract][Full Text] [Related]
3. Predictors of Long-Term Visual Acuity in a Modern Cohort of Patients With Acute Idiopathic and Multiple Sclerosis-Associated Optic Neuritis. Jarocki A; Benard-Seguin E; Gonzalez LA; Costello F; Andrews CA; Kerber K; De Lott LB J Neuroophthalmol; 2023 Dec; 43(4):475-480. PubMed ID: 37200095 [TBL] [Abstract][Full Text] [Related]
4. Association of race/ethnicity with visual outcomes following acute optic neuritis: an analysis of the Optic Neuritis Treatment Trial. Moss HE; Gao W; Balcer LJ; Joslin CE JAMA Ophthalmol; 2014 Apr; 132(4):421-7. PubMed ID: 24557028 [TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
6. Corticosteroids for treating optic neuritis. Gal RL; Vedula SS; Beck R Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD001430. PubMed ID: 26273799 [TBL] [Abstract][Full Text] [Related]
15. Real-world management of patients with neuromyelitis optica spectrum disorder using satralizumab: Results from a Japanese claims database. Nakashima I; Nakahara J; Yasunaga H; Yamashita M; Nishijima N; Satomura A; Nio M; Fujihara K Mult Scler Relat Disord; 2024 Apr; 84():105502. PubMed ID: 38401202 [TBL] [Abstract][Full Text] [Related]
16. Effect of Treating Acute Optic Neuritis With Bioequivalent Oral vs Intravenous Corticosteroids: A Randomized Clinical Trial. Morrow SA; Fraser JA; Day C; Bowman D; Rosehart H; Kremenchutzky M; Nicolle M JAMA Neurol; 2018 Jun; 75(6):690-696. PubMed ID: 29507942 [TBL] [Abstract][Full Text] [Related]
17. Incidence and Causes of Overdiagnosis of Optic Neuritis. Stunkel L; Kung NH; Wilson B; McClelland CM; Van Stavern GP JAMA Ophthalmol; 2018 Jan; 136(1):76-81. PubMed ID: 29222573 [TBL] [Abstract][Full Text] [Related]
20. Visual outcome after intravenous dexamethasone therapy for idiopathic optic neuritis in an Indian population: a clinical case series. Sethi HS; Menon V; Sharma P; Khokhar S; Tandon R Indian J Ophthalmol; 2006 Sep; 54(3):177-83. PubMed ID: 16921215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]